Stock Comparison

PLRZ vs UNH

Polyrizon Ltd vs UnitedHealth Group Inc

The Verdict

PLRZ takes this one.

Winner

PLRZ

Polyrizon Ltd

1.4

out of 10

Distressed

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$27M

Market Cap

$365.5B

7.3

P/E Ratio

30.3

N/A

Profit Margin

2.7%

-17.8%

Return on Equity

12.4%

N/A

Debt-to-Equity

0.8

Aggressive

Overall Risk

Moderate

1.4

DVR Score

0.3

The Deep Dive

PLRZ1.4/10

Polyrizon Ltd. (PLRZ) has undergone a significant shift from a seemingly defunct entity to an active, albeit extremely high-risk, development-stage biotech. The initiation of its first Clinical Trial Agreement for NASARIX™ (PL-14) Allergy Blocker and recent patent filings demonstrate verifiable operational progress and a strategic vision for capturing a large potential market (nasal barrier techno...

Full PLRZ Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.